The time to wake up the stock of giant Sinopharm is near
Sinopharm Group is a profitable Chinese state company with 2 covid-19 vaccines (the first is approved in China) with very strong fundamentals (except debt).
Sinopharms stock seems to be near the end of a many years correction, ready to reverse its declining trend.
Next follows the stocks mid-term trend chart.
Disclaimer
The writer of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.
Sinopharms stock seems to be near the end of a many years correction, ready to reverse its declining trend.
Next follows the stocks mid-term trend chart.
Disclaimer
The writer of this text is not an investment advisor. The preceding content is intended to be used for informational and educational purposes only. It is not an advice or inducement for the purchase or sale of the products mentioned. Before making any investment based on your own personal circumstances, it is very important to do your own research and analysis and also take independent financial advice from a professional to verify any information provided here.